By Maggie Fick and Jennifer Rigby LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving its current cost, they ...

Starting Monday, a new, highly effective malaria vaccine will be rolled out for the first time, as an immunization campaign for children kicks off in Cameroon.

When GSK heard that instead of triumphantly shipping malaria shots to Africa, it would have to put the vaccine through another evaluation, executives ordered that the production facility and the ...

As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices.

In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save thousands of children who suffer from malaria.

GSK ’s malaria vaccine—RTS,S or Mosquirix—was celebrated as a major public health milestone in 2021 when it became the first ever shot to get the green light for widespread use in children ...

Nearly half a million children younger than 5 die each year in Africa because of malaria, so great excitement accompanied the rollout July 15 of a second malaria vaccine — both released this year.

Just two years after the WHO’s historic recommendation of the first malaria vaccine, the global health agency on Monday recommended a second.

The World Health Organization has authorized a second malaria vaccine in a decision that could offer countries a cheaper and a more readily available option than the world’s first shot against ...